• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1550400-38
Medical Device Problem Code Difficult or Delayed Positioning (1157)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 08/28/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).The stent remains in the patient.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported difficult to deploy.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
 
Event or Problem Description
It was reported that the patient had a previously placed stent in a saphenous vein graft (svg) to the ostial posterior descending artery 10 years prior.This was another percutaneous coronary intervention to treat the same area.The lesion was a little eccentric with one focal stenosis at the ostium.During deployment of the xience sierra 4 x 38 mm stent at 10 atmospheres, the stent slipped back proximal toward the guide into the aorta.The ostial focal lesion was covered, however roughly 10mm of stent is now hanging outside the svg into the aorta.The stent balloon catheter was then re-advanced and inflated one more time to complete the procedure after taking a final angiogram.This was done to reinforce the stent to the vessel wall.The physician plans to keep patient on dual antiplatelet therapy for the remainder of his life.There was no reported adverse patient effect.There was no reported clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key7887265
Report Number2024168-2018-07263
Device Sequence Number1939860
Product Code NIQ
UDI-Device Identifier08717648227547
UDI-Public08717648227547
Combination Product (Y/N)N
Initial Reporter StateKY
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial
Report Date (Section B) 09/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/13/2019
Device Catalogue Number1550400-38
Device Lot Number8060741
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/28/2018
Initial Report FDA Received Date09/18/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age77 YR
-
-